Cointime

Xanodyne

company

About

Xanodyne Pharmaceuticals is an integrated specialty pharmaceutical company focused on women’s healthcare and pain management.

  • 51 - 100

Highlights

Total Funding Amount
$87.78M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$87.78M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2000
Number Of Employee
51 - 100
Operating Status
Active

Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company that offers developing and commercializing products in women’s healthcare and pain management in the United States.The company was formerly known as Xanodyne Pharmacal, Inc. and changed the name to Xanodyne Pharmaceuticals, Inc. in February, 2004. Xanodyne Pharmaceuticals, Inc. was incorporated in 2000 and is based in Newport, Kentucky.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$87.78M
Xanodyne has raised a total of $87.78M in funding over 2 rounds. Their latest funding was raised on Oct 30, 2009 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 30, 2009 Series Unknown $87.78M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Xanodyne is funded by 1 investors. Perseus-Soros Biopharmaceutical Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Perseus-Soros Biopharmaceutical Fund — Series Unknown
Cointime
เนื้อหา
บริษัท